DERMATOLOGY FOR PRIMARY CARE
Walt Disney World Resort, Florida – Disney’s Grand Floridian Resort and Spa
April 17 – 19, 2015
Participating Faculty
Whitney A. High, MD, JD, MEng
Associate Professor, Dermatology and Pathology
Director of Dermatopathology (Dermatology)
University of Colorado School of Medicine
Denver, Colorado
Misha D. Miller, MD, FACOG, FAAD
Assistant Clinical Professor
Department of Dermatology
University of Colorado School of Medicine
Denver, Colorado
Lori Prok, MD
Assistant Professor
Pediatric Dermatology and Dermatopathology
University of Colorado Denver and Children’s Hospital Colorado
Denver, Colorado
Whitney A. High, MD, JD, MEng
Associate Professor, Dermatology and Pathology
Director of Dermatopathology (Dermatology)
University of Colorado School of Medicine
Denver, Colorado
Dr. High received his Bachelor's degree and Master's degree in Chemical Engineering
from the Colorado School of Mines in Golden, Colorado. After spending time in industry,
he returned to medical school to earn his medical degree from Mayo Clinic, where he
graduated at the top of his class. He also holds a law degree.
After medical school, Dr. High completed his dermatology residency at the University of
Texas Southwestern Medical Center in Dallas, where he served as Chief Resident. He
then returned to Colorado to complete a dermatopathology fellowship at the University
of Colorado, where he remained on faculty. He was the youngest person ever appointed
to Associate Professor in the Department of Dermatology, and also serves as the Vice
Chairman for Clinical Affairs in that department.
Dr. High has a diploma in Tropical Medicine & Hygiene from the Gorgas Institute, and
has recognized expertise in infectious dermatology. He is the author of more than two
dozen book chapters, more than 65 indexed peer-reviewed articles, and three
textbooks. Dr. High serves as an Assistant Editor for the Journal of the American
Academy of Dermatology. His research laboratory was the first to discover gadolinium
in the skin in nephrogenic systemic fibrosis, leading in part to a new black box warning
on that medication.
Dr. High is nationally recognized in his field, and he has given lectures in dermatology
throughout the United States and in international forums as well. He is board-certified
both in Dermatology and Dermatopathology and maintains active and robust practices.
He is married to another dermatologist and has two small children.
Misha D. Miller, MD, FACOG, FAAD
Assistant Clinical Professor
Department of Dermatology
University of Colorado School of Medicine
Denver, Colorado
Dr. Miller received her undergraduate degree from Southern Methodist University in
Dallas, Texas and her medical degree from Mayo Medical School in Rochester,
Minnesota. She completed a residency in Obstetrics and Gynecology at the University
of Texas Southwestern Medical Center-Parkland Hospital in Dallas. Dr. Miller recently
completed a residency in Dermatology and a Procedural Dermatology Fellowship at the
University of Colorado, Denver School of Medicine. She is board certified in Obstetrics
and Gynecology and Dermatology. Dr. Miller has received several awards and honors
such as the Medicus Award for Outstanding Clinical Care, Knowledge, Teaching, and
Dedication to Compassion and Professionalism from the University of Texas
Southwestern Medical Center. She has published in Peer Reviewed publications and
poster presentations. Dr. Miller is in private practice in Denver.
Lori D. Prok, MD
Assistant Professor
Pediatric Dermatology and Dermatopathology
University of Colorado Denver and Children’s Hospital Colorado
Denver, Colorado
Dr. Prok received her undergraduate degree from the University of Colorado at Boulder
and her medical degree from the University of Colorado School of Medicine in Denver.
She completed her Pediatrics residency at Children’s Hospital Colorado, and her
Dermatology residency and Dermatopathology fellowship at the University of Colorado
Denver.
Dr. Prok is a member of the American Academy of Pediatrics, the American Academy of
Dermatology, Society for Pediatric Dermatology, and a former Executive Board member
of the Colorado Dermatologic Society. Dr. Prok has published articles in numerous
peer-reviewed journals, and is an author for UpToDate and six textbooks on
dermatology, pediatrics, and pathology. She is active in presenting at national medical
conferences. Dr. Prok enjoys teaching, and was awarded Outstanding Clinical
Instructor by the University of Colorado School of Medicine in 2002 and the Golden
Stethescope Award for medical student mentorship in 2012. She is a Children’s
Advocacy Committee member of Children’s Hospital Colorado, and has served as a
Steering Committee Member and volunteer clinician with Healthy Beginnings Clinic in
Denver, providing free medical care to children of single, low-income parents in Denver.
Friday, April 17th:
7:30 am – 8:00 am
Registration and Hot Breakfast
8:00 am – 9:00 am – Lori Prok, MD
Dermatitis
Contact, atopic, irritant, nummular, seborrheic and exfoliative; diagnosis and
management
9:00 am – 10:00 am – Lori Prok, MD
Papulosquamous Diseases
Psoriasis, lichen planus, pityriasis rosea, lupus erythematosus; how to tell one scaly
rash from another
10:00 am – 10:10 am
Coffee Break
10:10 am – 11:10 am – Whitney A. High, MD, JD, MEng
Bacterial Infections
Impetigo, ecthyma, folliculitis, furunculosis, necrotizing fasciitis, Lyme disease, syphilis;
diagnosis and management
11:10 am – 11:40 am – Whitney A. High, MD, JD, MEng
Acne and Acneiform Eruptions
Topical and systemic therapy
11:40 am – 12:40 pm – Lori Prok, MD
Viral Infections
Herpes simplex, varicella-zoster, viral exanthems, molluscum and warts
12:40 pm
Session Adjourns
Saturday, April 18th:
7:30 am – 8:00 am
Hot Breakfast
8:00 am – 9:00 am – Whitney A. High, MD, JD, MEng
Skin Manifestations of Systemic Disease
Diagnosis of internal disease based on cutaneous findings
9:00 am – 9:30 am – Whitney A. High, MD, JD, MEng
Case Presentations
9:30 am – 10:30 am – Lori Prok, MD
Fungal Infections
Dermatophytes, tinea versicolor, candidiasis, selected deep fungal infections; diagnosis
and management
10:30 am – 10:40 am
Coffee Break
10:40 am – 11:40 am – Misha D. Miller, MD, FACOG, FAAD
Benign Skin Tumors.
Nevi, seborrheic keratosis keloids, hemangiomas and miscellaneous tumors
11:40 am – 12:40 pm – Misha D. Miller, MD, FACOG, FAAD
Skin Surgery for Primary Care
12:40 pm
Session Adjourns
Sunday, April 19th:
7:30 am – 8:00 am
Continental Breakfast
8:00 am – 9:00 am – Misha D. Miller, MD, FACOG, FAAD
Premalignant and Malignant Skin Tumors
Actinic keratosis, Bowen’s disease, squamous cell carcinoma, basal cell carcinoma,
melanoma and other selected tumors
9:00 am – 10:00 am – Misha D. Miller, MD, FACOG, FAAD
Case Presentations
10:00 am
Conference Adjourns
Target Audience
This program is targeted to office-based primary care providers and other health professionals
with updates in primary care medicine
Learning Objectives
Upon completion of this program, participants should be better able to:
• Discriminate the diagnostic principles and treatment options for dermatitis,
papulosquamous diseases, as well as viral, fungal and bacterial infections
• Describe the step-wise approach for the diagnosis and treatment of acne and acneiform
eruptions
• Identify cutaneous findings that serve as surrogates of internal diseases
• Differentiate benign and malignant skin tumors and employ appropriate interoffice
procedures
• Counsel patients on appropriate sun protection measures
Nursing Purpose Statement
To provide updates in primary care medicine to office based providers
Disclosure of Conflicts of Interest
Medical Education Resources insures balance, independence, objectivity, and scientific rigor in
all our educational programs. In accordance with this policy, MER identifies conflicts of interest
with its instructors, content managers, and other individuals who are in a position to control the
content of an activity. Conflicts are resolved by MER to ensure that all scientific research
referred to, reported, or used in a CME activity conforms to the generally accepted standards of
experimental design, data collection, and analysis. MER is committed to providing its learners
with high-quality CME activities that promote improvements or quality in health care and not the
business interest of a commercial interest.
The faculty reported the following financial relationships with commercial interests whose
products or services may be mentioned in this CME activity:
Name of Faculty
Reported Financial Relationship
Whitney A. High, MD, JD, MEng
No financial relationships to disclose
Misha D. Miller, MD, FACOG, FAAD
No financial relationships to disclose
Lori Prok, MD
No financial relationships to disclose
The content managers reported the following financial relationships with commercial interests
whose products or services may be mentioned in this CME activity:
Name of Content Manager
Reported Financial Relationship
MER content managers
No financial relationships to disclose
MER nurse planner
No financial relationships to disclose
Disclaimer
The content, views and opinions presented in this educational activity are those of the authors
and do not necessarily reflect those of Medical Education Resources. The authors have
disclosed if there is any discussion of published and/or investigational uses of agents that are
not indicated by the FDA in their presentations. Before prescribing any medicine, primary
references and full prescribing information should be consulted. Any procedures, medications,
or other courses of diagnosis or treatment discussed or suggested in this activity should not be
used by clinicians without evaluation of their patient’s conditions and possible contraindications
on dangers in use, review of any applicable manufacturer’s product information, and
comparison with recommendations of other authorities. The information presented in this activity
is not meant to serve as a guideline for patient management.
All lectures incorporate time for questions and answers.
Due to last-minute updates by the faculty, flash drives may differ from the actual presentations.
Accreditation
Physician Accreditation
Medical Education Resources is accredited by the Accreditation Council for Continuing Medical
Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
Medical Education Resources designates this live activity for a maximum of 11 AMA PRA
Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent
of their participation in the activity.
American Academy of Family Physicians
This Live activity, Dermatology for Primary Care, with a beginning date of April 17, 2015 has
been reviewed and is acceptable for up to 11 Prescribed credits by the American Academy of
Family Physicians. Physicians should only claim the credit commensurate with the extent of
their participation in the activity.
American Osteopathic Association
These programs are approved for 11 hours in Category 2-A by the American Osteopathic
Association.
Canadian Physicians
The College of Family Physicians of Canada (CFPC) has a reciprocal credit agreement with the
American Academy of Family Physicians (AAFP) for activities which offer Prescribed credit.
CFPC members who complete these conferences may claim the equivalent number of MainproM1 credits.
American Academy of Physician Assistants
AAPA accepts certificates of participation for educational activities certified for Category I credit
from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 Credit(s)TM from
organizations accredited by ACCME or a recognized state medical society. Physician
assistants may receive a maximum of 11 hours of Category I credit for completing this program.
Nursing Accreditation
Medical Education Resources is accredited as a provider of continuing nursing education by the
American Nurses Credentialing Center’s Commission on Accreditation.
This CE activity provides 11 contact hours of continuing nursing education.
Provider approved by the California Board of Registered Nursing, Provider Number 12299, for
11 contact hours.
Pharmacy Accreditation
Medical Education Resources (MER) is accredited by the Accreditation Council
for Pharmacy Education as a provider of continuing pharmacy education. MER
designates this continuing education activity for 11 contact hours (1.1 CEUs) of
the Accreditation Council for Pharmacy Education.
Universal Program Number: 0816-0000-15-XXX-L01-P
Participants will be required to sign in at the start of the program and/or complete a program
evaluation form. Certificates of credit will be provided at the conclusion of the activity.
This activity is certified as Knowledge-based CPE.